Shares of Medtronic ( NYSE: MDT ) are marginally up 0.33% on Friday midday trading after rallying for the past seven trading sessions, where shares climbed overall 9.48% from the bottom of $80.
78 to a high of $89.24. YTD the MDT stock jumped 6.
31%, while the S&P 500 was up 18.5% while the Dow Jones Industrial Average climbed 8.89%.
Over the year, the stock jumped 5.31% so far, compared to the nearly 26.7% rise in the broader S&P 500 Index.
MDT rallied 10.98% over the past one month. The stock closed 0.
59% higher on Friday at $88.35. Looking at Seeking Alpha’s Quant rating , MDT has a score of 3.
20 out of 5. The company received A+ in the prospect of profitability, while it got an D- in valuation and F in growth factors. Turning to the Wall Street community, almost 11 analysts gave MDT a Strong Buy while 5 stood with Buy whereas, 15 of them gave the stock a Hold recommendation, and just 2 were on the short side.
Seeking Alpha analysts also see the stock as a Buy . As for the guide, Medtronic now expects FY 2025 organic sales growth to be in the 4% to 5% range, ex-currency impacts. There could be an FX tailwind in the quarter now underway, given that the US Dollar Index has slumped to its worst level since January.
The management team forecasts 2025 diluted non-GAAP EPS of $5.40 to $5.50 .
More on Medtronic Medtronic plc (MDT) Q1 2025 Earnings Call Transcript Medtronic plc 2025 Q1 - Results - Earnings Call Presentation Medtronic: Healthy Vital Signs Heading Into Earnings Medtronic raises fiscal 2025 guidance following strong Q1 results Medtronic Non-GAAP EPS of $1.23 beats by $0.03, revenue of $8B beats by $100M.
